The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes

Por Aboumrad, E, Madec, A M, Thivolet, C
Publicado em 2007

Anti-tubulin antibodies in autoimmune thyroid disorders.

Por Rousset, B, Bernier-Valentin, F, Poncet, C, Orgiazzi, J, Madec, A M, Monier, J C, Mornex, R
Publicado em 1983

T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes

Por RHARBAOUI, F, MAYER, A, GRANIER, C, BOUANANI, M, THIVOLET, C, PAU, B, ORGIAZZI, J, MADEC, A -M
Publicado em 1999

Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient

Por BANGA, J P, MOORE, J K, DUHINDAN, N, MADEC, A M, VAN ENDERT, P M, ORGIAZZI, J, ENDL, J
Publicado em 2004

Multiplicity of the antibody response to GAD65 in Type I diabetes

Por GILLIAM, L K, BINDER, K A, BANGA, J P, MADEC, A-M, ORTQVIST, E, KOCKUM, I, LUO, D, HAMPE, C S
Publicado em 2004

Protection of Human Pancreatic Islets from Lipotoxicity by Modulation of the Translocon

Por Cassel, R., Ducreux, S., Alam, M. R., Dingreville, F., Berlé, C., Burda-Jacob, K., Chauvin, M. A., Chikh, K., Païta, L., Al-Mawla, R., Crola Da Silva, C., Rieusset, J., Thivolet, C., Van Coppenolle, F., Madec, A. M.
Publicado no PLoS One (2016)